approval
saveTYENNE (TOCILIZUMAB-AAZG) — FDA approval
community read0 votes
Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INTRAVENOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 7
- approvalTYENNE (TOCILIZUMAB-AAZG) — FDA approvalJan 21, 2026 · 257d ago
- approvalTYENNE (TOCILIZUMAB-AAZG) — FDA approvalMay 12, 2025 · 511d ago
- approvalTYENNE (TOCILIZUMAB-AAZG) — FDA approvalFeb 28, 2025 · 584d ago
- approvalTYENNE (TOCILIZUMAB-AAZG) — FDA approvalDec 13, 2024 · 661d ago
- approvalTYENNE (TOCILIZUMAB-AAZG) — FDA approvalDec 3, 2024 · 671d ago
- approvalTYENNE (TOCILIZUMAB-AAZG) — FDA approvalSep 5, 2024 · 760d ago
- approvalTYENNE (TOCILIZUMAB-AAZG) — FDA approvalMar 5, 2024 · 944d ago
same company · ±60 days · 6
- approvalOTULFI: OTULFI (USTEKINUMAB-AAUZ) — FDA approvalMar 21, 2025
- approvalCONEXXENCE: CONEXXENCE (DENOSUMAB-BNHT) — FDA approvalMar 25, 2025
- approvalTYENNE: TYENNE (TOCILIZUMAB-AAZG) — FDA approvalFeb 28, 2025
- approvalSTIMUFEND: STIMUFEND (PEGFILGRASTIM-FPGK) — FDA approvalMar 26, 2025
- approvalOTULFI: OTULFI (USTEKINUMAB-AAUZ) — FDA approvalFeb 19, 2025
- approvalOTULFI: OTULFI (USTEKINUMAB-AAUZ) — FDA approvalApr 14, 2025
comments(0)
5-min edit window · permanent after that